Research peptides for sale. Documented from the published record.
Synthesized research compounds with plain-language research pages and links to the original papers — including the findings that cut against them. For laboratory research only.
Synthesized research compounds with plain-language research pages and links to the original papers — including the findings that cut against them. For laboratory research only.
Every peptide cross-referenced to the published literature. No interpretation — primary sources only.
Peptide Research Research Education
Sermorelin is GHRH(1-29), the shortest fragment of growth hormone-releasing hormone that still works. Its human record is 1990s pediatric growth trials and adult physiology studies, and it has no meta-analysis.
Read DetailsClinical Research Regulatory & Legal
The WADA 2026 Prohibited List names sermorelin, CJC-1295, tesamorelin and ipamorelin by name under section S2.2.4. Here is the entry, quoted from the List itself.
Read DetailsPeptide Research Research Education
Sermorelin, CJC-1295 and ipamorelin are three different molecules, two receptors and three very different evidence bases. What each one's published record actually contains.
Read DetailsQuality & Testing Research & Quality
Sermorelin is GHRH(1-29) amide: 29 residues, molecular weight 3357.9, CAS 86168-78-7, PubChem CID 16132413. Why the brand name resolves to three other records, and how sermorelin differs from tesamorelin and native GHRH.
Read DetailsClinical Research Regulatory & Legal
What the sermorelin trials reported on safety: no adverse biochemical changes in the largest pediatric study, near-universal antibody formation in a randomized one, and an FDA determination that discontinuation was not for safety reasons.
Read DetailsPeptide Research Research Education
Selank is a seven-amino-acid peptide built from tuftsin, studied in Russia since the 1990s. What the published research covers, what the human trials compared it against, and what is missing.
Read DetailsClinical Research Regulatory & Legal
Sermorelin's human trial record is 1990s pediatric growth studies and adult physiology work. In the one three-arm randomized comparison, growth hormone outgrew it and 39 of 40 treated children developed antibodies.
Read DetailsPeptide Research Research Education
Selank was tested against alcohol and morphine withdrawal in rodents, with diazepam as the comparator. The published comparison says Selank was slightly inferior — not comparable.
Read Details